New course of treatment with existing drugs for cervical can

A course of treatment with existing drugs prior to chemoradiation led to a 35% reduction in the risk of death or return of cancer, in trial results presented by researchers from UCL and UCLH.

Related Keywords

Italy , India , Mexico , United Kingdom , Brazil , Megan Craig , Jonathan Ledermann , Mary Mccormack , Iain Foulkes , Cancer Trials Centre , European Society For Medical Oncology , Cancer Institute , Cancer Research United Kingdom , Trials Centre , European Society , Medical Oncology , Executive Director , Cancer , Cervical Cancer , Drugs , Carboplatin , Chemotherapy , Ncology , Paclitaxel , Research ,